Biogen Inc

Sümbol: 0R1B.L

LSE

220.98

USD

Turuhind täna

  • 27.5773

    P/E suhe

  • 0.4723

    PEG suhe

  • 32.12B

    MRK Cap

  • 0.00%

    DIV tootlus

Biogen Inc (0R1B-L) Finantsaruanded

Diagrammil näete Biogen Inc (0R1B.L) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Bilanss

Sukeldudes Biogen Inc fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

01049.94892.83802.5
2610.1
4475.9
3538
3689
4895.1
3428.5
1845.4
1222.7
1705.7

balance-sheet.row.short-term-investments

001473.51541.1
1278.9
1562.2
2313.4
2115.2
2568.6
2120.5
640.5
620.2
1135

balance-sheet.row.net-receivables

021002136.41961.7
2327.3
2470.7
2485.4
2319.6
1742.2
1541.5
1575.8
1077.1
955.2

balance-sheet.row.inventory

02527.41344.41351.5
1068.6
804.2
929.9
902.7
1001.6
893.4
804
659
447.4

balance-sheet.row.other-current-assets

011821417.6740.8
881.1
631
687.6
962
1093.3
836.9
309.8
226.1
136

balance-sheet.row.total-current-assets

06859.39791.27856.5
6887.1
8381.8
7640.9
7873.3
8732.2
6700.3
4535
3184.9
3244.3

balance-sheet.row.property-plant-equipment-net

03729.73702.53791.8
3844.8
3674.3
3601.2
3182.4
2501.8
2187.6
1765.7
1750.7
1742.2

balance-sheet.row.goodwill

06219.257495761.1
5762.1
5757.8
5706.4
4632.5
3669.3
2663.8
1760.2
1232.9
1201.3

balance-sheet.row.intangible-assets

001850.12221.3
3084.3
3527.4
3120
3879.6
3808.3
4085.1
4028.5
4474.7
1631.5

balance-sheet.row.goodwill-and-intangible-assets

06219.27599.17982.4
8846.4
9285.2
8826.4
8512.1
7477.6
6748.9
5788.7
5707.6
2832.8

balance-sheet.row.long-term-investments

0460.71957.12602.2
3416.9
2382.2
3059.9
3465.9
4120.8
3827.5
2210.8
1202.7
2293.1

balance-sheet.row.tax-assets

0928.61226.41415.1
1369.5
3232.1
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

08647.3277.8229.3
254.2
278.7
-15487.5
-15160.4
-14100.2
-12764
-9765.2
-8661
-6868.2

balance-sheet.row.total-non-current-assets

019985.514762.916020.8
17731.8
18852.5
15487.5
15160.4
14100.2
12764
9765.2
8661
6868.2

balance-sheet.row.other-assets

0000
0
0
2160.5
618.9
44.4
40.5
14.5
17.4
17.6

balance-sheet.row.total-assets

026844.824554.123877.3
24618.9
27234.3
25288.9
23652.6
22876.8
19504.8
14314.7
11863.3
10130.1

balance-sheet.row.account-payables

0403.3491.5589.2
454.9
530.8
370.5
395.5
279.8
267.4
229.2
219.9
204

balance-sheet.row.short-term-debt

0240.397.21088.2
83.2
1569.4
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

0257.4259.9174.7
142
71.4
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

06788.262816274
7426.2
4459
5936.5
5935
6512.7
6521.5
580.3
592.4
687.4

Deferred Revenue Non Current

0400333330.4
402
412.7
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

02533.32424.22446.1
3062.1
2692.2
2924.7
2972.7
3140.1
2310.3
1988.9
1538.4
1453.4

balance-sheet.row.total-non-current-liabilities

08611.17892.98619.4
10190.6
9031.4
5936.5
5935
6512.7
6521.5
580.3
592.4
687.4

balance-sheet.row.other-liabilities

0000
0
0
3025.6
1751.3
815.6
1030.7
702.3
891.8
821.5

balance-sheet.row.capital-lease-obligations

0400333330.4
402
412.7
0
0
0
0
0
0
0

balance-sheet.row.total-liab

012045.411165.712917.6
13932.8
13895.2
12257.3
11054.5
10748.2
10129.9
3500.7
3242.5
3166.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.10.10.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

balance-sheet.row.retained-earnings

017627.616466.513911.7
13976.3
16455.4
16257
15810.4
15071.6
12208.4
9283.9
6349.1
4486.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-153.7-164.9-106.7
-299
-135.2
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-2674.6-2903.8-2908.9
-2977.1
-2977.1
-3217.5
-3197.7
-2931.6
-2835.7
1525
2271
2474.6

balance-sheet.row.total-stockholders-equity

014799.413397.910896.2
10700.3
13343.2
13039.6
12612.8
12140.1
9372.8
10809
8620.2
6961.5

balance-sheet.row.total-liabilities-and-stockholders-equity

026844.824554.123877.3
24618.9
27234.3
0
0
0
0
0
0
0

balance-sheet.row.minority-interest

00-9.563.5
-14.2
-4.1
-8
-14.7
-11.5
2.1
5
0.6
2.3

balance-sheet.row.total-equity

014799.413388.410959.7
10686.1
13339.1
13031.6
12598.1
12128.6
9374.9
10814
8620.8
6963.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-

Total Investments

0460.73430.64143.3
4695.8
3944.4
5373.3
5581.1
6689.4
5948
2851.3
1822.9
3428.1

balance-sheet.row.total-debt

07428.56711.27692.6
7911.4
6441.1
0
0
0
0
0
0
0

balance-sheet.row.net-debt

06378.63291.95431.2
6580.2
3527.4
-1224.6
-1573.8
-2326.5
-1308
-1204.9
-602.6
-570.7

Rahavoogude aruanne

Biogen Inc finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

cash-flows.row.net-income

01161.13046.91556.1
4000.6
5888.5
4430.7
2539.1
3702.8
3547
2934.8
1862.3
1380

cash-flows.row.depreciation-and-amortization

0494.8518.7487.3
457
464.6
650.5
721.6
637.2
600.4
637.2
531.7
365.6

cash-flows.row.deferred-income-tax

0-305.8-168.6-426.8
149
67.1
87.2
370
217.2
-50.9
455.9
124.5
-42.2

cash-flows.row.stock-based-compensation

0-1063.8264.3250.8
205.1
216.5
170.1
160.1
189.8
196.3
242.4
246.1
178.9

cash-flows.row.change-in-working-capital

0-648.7-890.3-145.5
-187.2
199.3
-257.3
-530.1
-407
-145.4
-698.3
-370.6
-136.7

cash-flows.row.account-receivables

056.7-222.4326
179.5
5.5
-205.2
-435.6
-241.4
29
-512.4
-126.7
3.6

cash-flows.row.inventory

0-130.9-320.2-462.4
-316.3
-19.2
-52.1
-94.5
-165.6
-174.4
-185.9
-243.9
-140.3

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-574.5-347.7-9.1
-50.4
213
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

01909.6-1386.71918
-394.7
242.6
1106.5
1660.3
464.4
-278.9
-174
75.6
92.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-7237.5-243.2-294.9
-551.8
-669.5
-770.6
-867.4
-616.1
-643
-287.8
-246.3
-254.5

cash-flows.row.acquisitions-net

012.359528.1
0
179.3
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-5140.7-3448.5-3808.7
-7404.2
-5252.6
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

08288.54661.33498.9
7374.3
6486.3
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0-11.324.412.9
-26.9
-273
-1275.7
-2095.7
-1868.7
-3910.6
-1255.2
-1358.4
-695.8

cash-flows.row.net-cash-used-for-investing-activites

0-4088.71589-563.7
-608.6
470.5
-2046.3
-2963.1
-2484.8
-4553.6
-1543
-1604.7
-950.3

cash-flows.row.debt-repayment

0-187.3-1002.2-170
-1467.4
0
-3.2
-560.9
-2.7
-2.1
-2.7
-452.4
-2.4

cash-flows.row.common-stock-issued

0-44.3-1.9-0.7
-4.6
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-750-1800
-6679.1
-5868.3
-4352.6
-1365.4
-1000
-5000
-886.8
-400.3
-984.7

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-6-5.6-115.5
-56.4
7.9
-116.2
-453.7
-49.9
5785.2
133.6
136.2
109.7

cash-flows.row.net-cash-used-provided-by-financing-activities

0137-1759.7-2086.2
-5272.7
-5860.4
-4472
-2380
-1052.6
783.1
-755.9
-716.5
-877.5

cash-flows.row.effect-of-forex-changes-on-cash

035.1-55.7-59.8
69
0.4
-18.6
39.4
-31.3
-45.8
-40.9
8
4.1

cash-flows.row.net-change-in-cash

0-2369.41157.9930.2
-1582.5
1689.1
-349.2
-752.7
1018.5
103.1
602.3
31.9
56.2

cash-flows.row.cash-at-end-of-period

01049.93419.32261.4
1331.2
2913.7
1224.6
1573.8
2326.5
1308
1204.9
602.6
570.7

cash-flows.row.cash-at-beginning-of-period

03419.32261.41331.2
2913.7
1224.6
1573.8
2326.5
1308
1204.9
602.6
570.7
514.5

cash-flows.row.operating-cash-flow

01547.21384.33639.9
4229.8
7078.6
6187.7
4551
4587.2
3919.4
2942.1
2345.1
1879.9

cash-flows.row.capital-expenditure

0-7237.5-243.2-294.9
-551.8
-669.5
-770.6
-867.4
-616.1
-643
-287.8
-246.3
-254.5

cash-flows.row.free-cash-flow

0-5690.31141.13345
3678
6409.1
5417.1
3683.6
3971.1
3276.4
2654.3
2098.8
1625.3

Kasumiaruande rida

Biogen Inc tulud muutusid võrreldes eelmise perioodiga NaN%. 0R1B.L brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

income-statement-row.row.total-revenue

094179433.410402.4
12356
12714
13452.9
12273.9
11448.8
10763.8
9703.3
6932.2
5514.9

income-statement-row.row.cost-of-revenue

03028.227972597
2262.2
2420
1816.3
1630
1433.2
1240.4
1171
857.7
545.5

income-statement-row.row.gross-profit

06388.86636.47805.4
10093.8
10294
11636.6
10643.9
10015.6
9523.4
8532.3
6074.5
4969.4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

04757.54362.34940.2
6293.5
4464.7
5648.9
5342.8
4886
4695.2
4583.5
3587.5
3111.8

income-statement-row.row.cost-and-expenses

07785.77159.37537.2
8555.7
6884.7
7465.2
6972.8
6319.2
5935.6
5754.5
4445.2
3657.3

income-statement-row.row.interest-income

0276.589.311
42
120
88.1
172.3
196.6
73.4
17.3
23.7
7

income-statement-row.row.interest-expense

0268.6263.7289.9
291
256.2
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-334.51317.7-1120
1247.2
1296.6
-464.5
-757.5
-775.8
-260.1
-36.2
-26.7
12.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

0-334.51317.7-1120
1247.2
1296.6
-464.5
-757.5
-775.8
-260.1
-36.2
-26.7
12.1

income-statement-row.row.interest-expense

0268.6263.7289.9
291
256.2
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

0494.8518.7487.3
457
464.6
650.5
721.6
637.2
600.4
637.2
531.7
365.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

01631.32274.12865.2
3800.3
5829.3
6364.1
5886.3
5708.8
5014.9
3967.7
2490
1838.5

income-statement-row.row.income-before-tax

01296.83591.81745.2
5047.5
7125.9
5899.6
5128.8
4933
4754.8
3931.5
2463.3
1850.6

income-statement-row.row.income-tax-expense

0135.3632.852.5
992.3
1158
1425.6
2458.7
1237.3
1161.6
989.9
601
470.6

income-statement-row.row.net-income

01161.13046.91556.1
4000.6
5888.5
4430.7
2539.1
3702.8
3547
2934.8
1862.3
1380

Korduma kippuv küsimus

Mis on Biogen Inc (0R1B.L) koguvara?

Biogen Inc (0R1B.L) koguvara on 26844800000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.678.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -39.271.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.123.

Mis on ettevõtte kogutulu?

Kogutulu on 0.173.

Mis on Biogen Inc (0R1B.L) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 1161100000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 7428500000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 4757500000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.